1. Home
  2. KTB vs IOVA Comparison

KTB vs IOVA Comparison

Compare KTB & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTB
  • IOVA
  • Stock Information
  • Founded
  • KTB 2018
  • IOVA 2007
  • Country
  • KTB United States
  • IOVA United States
  • Employees
  • KTB N/A
  • IOVA N/A
  • Industry
  • KTB Apparel
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KTB Consumer Discretionary
  • IOVA Health Care
  • Exchange
  • KTB Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • KTB 4.2B
  • IOVA 3.6B
  • IPO Year
  • KTB N/A
  • IOVA N/A
  • Fundamental
  • Price
  • KTB $71.06
  • IOVA $9.18
  • Analyst Decision
  • KTB Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • KTB 8
  • IOVA 10
  • Target Price
  • KTB $76.86
  • IOVA $24.80
  • AVG Volume (30 Days)
  • KTB 299.3K
  • IOVA 6.2M
  • Earning Date
  • KTB 10-31-2024
  • IOVA 11-05-2024
  • Dividend Yield
  • KTB 2.82%
  • IOVA N/A
  • EPS Growth
  • KTB 17.00
  • IOVA N/A
  • EPS
  • KTB 4.23
  • IOVA N/A
  • Revenue
  • KTB $2,562,440,000.00
  • IOVA $32,772,000.00
  • Revenue This Year
  • KTB $1.21
  • IOVA $13,836.92
  • Revenue Next Year
  • KTB $3.33
  • IOVA $183.20
  • P/E Ratio
  • KTB $16.70
  • IOVA N/A
  • Revenue Growth
  • KTB N/A
  • IOVA 13669.75
  • 52 Week Low
  • KTB $39.90
  • IOVA $3.21
  • 52 Week High
  • KTB $75.17
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • KTB 47.18
  • IOVA 38.75
  • Support Level
  • KTB $71.84
  • IOVA $10.32
  • Resistance Level
  • KTB $73.25
  • IOVA $11.80
  • Average True Range (ATR)
  • KTB 1.44
  • IOVA 0.64
  • MACD
  • KTB -0.34
  • IOVA -0.31
  • Stochastic Oscillator
  • KTB 16.46
  • IOVA 10.27

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: